Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Amgen
NCT07158697 · Cardiometabolic Diseases, Multimorbidity
NCT06593327 · Type 2 Diabetes, Diabetic Cardiomyopathy, and more
NCT07148817 · Cardiometabolic Diseases, Noise Exposure
NCT06136793 · Healthy Lifestyle, Home Environment Related Disease, and more
NCT07386665 · Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Diseases, and more
Anaheim Clinical Trials
Anaheim, California
Carilion Medical Center
Lake Forest, California
Fomat Medical Research
Oxnard, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions